MONCTON, New Brunswick, March 16, 2018 -- Organigram Holdings Inc. (TSX-V:OGI) (OTCQB:OGRMF) (the “Company” or “Organigram”), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that preparations are underway for the Company’s second career fair, to be held at the Delta Beausejour (750 Main St., Moncton) from 10 a.m. to 3 p.m. on March 24, 2018.
Organigram is seeking to add more than 100 employees in multiple disciplines within the business, with immediate needs in the Company’s production and sanitation teams.
Organigram is anticipating significant business growth as the company expands its existing medical cannabis production and prepares for the adult recreational cannabis market. The company has just completed Phase 2 of an estimated $35-million expansion at its production facility located in the Moncton Industrial Park and is preparing to finish an additional expansion in May.
“Organigram remains committed to continued and growing leadership as Canada and the cannabis industry heads toward a legal adult recreational use cannabis market,” says Greg Engel, CEO, Organigram. “Producing products of the highest quality are our first priority – and that begins with hiring and developing exceptional teams. We look forward to drawing from the rich talent pool located right here in New Brunswick.”
Organigram’s Moncton facility currently employs approximately 170 employees. That number is expected to grow beyond 270 by the end of 2018.
Those interested in pursuing a career in Production or Sanitation at Organigram are encouraged to attend the company’s #DiscoverOGI Career Day, scheduled to take place in Beausejour Room A at the Delta Beausejour (750 Main St., Moncton) from 10 a.m. to 3 p.m. on March 24.
Minimum hiring criteria:
- Ability to hold and maintain Security Clearance as per the Access to Cannabis for Medical Purposes Regulations
- Current resume
- Satisfactory criminal record check
About Organigram Holdings Inc.:
Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
Organigram has been ranked in the top ten Clean Technology & Life Sciences Sector on the TSX Venture Exchange 50.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations. Important factors - including the availability of funds, consummation of definitive documentation, the results of financing efforts, crop yields - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
-30-
For media requests, please contact: For Career Fair information, please contact:
Organigram Holdings Inc. Organigram Holdings Inc
Ray Gracewood Giselle Doiron
Chief Commercial Officer [email protected]
[email protected] (506) 801-8986